Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Nurix Therapeutics (NRIX) Revenue: 2019-2024

Historic Revenue for Nurix Therapeutics (NRIX) over the last 6 years, with Nov 2024 value amounting to $54.5 million.

  • Nurix Therapeutics' Revenue fell 37.29% to $7.9 million in Q3 2025 from the same period last year, while for Aug 2025 it was $83.7 million, marking a year-over-year increase of 48.32%. This contributed to the annual value of $54.5 million for FY2024, which is 29.15% down from last year.
  • According to the latest figures from FY2024, Nurix Therapeutics' Revenue is $54.5 million, which was down 29.15% from $77.0 million recorded in FY2023.
  • Nurix Therapeutics' Revenue's 5-year high stood at $77.0 million during FY2023, with a 5-year trough of $17.8 million in FY2020.
  • For the 3-year period, Nurix Therapeutics' Revenue averaged around $56.7 million, with its median value being $54.5 million (2024).
  • Per our database at Business Quant, Nurix Therapeutics' Revenue crashed by 42.73% in 2020 and then surged by 99.31% in 2023.
  • Yearly analysis of 5 years shows Nurix Therapeutics' Revenue stood at $17.8 million in 2020, then skyrocketed by 66.95% to $29.8 million in 2021, then climbed by 29.84% to $38.6 million in 2022, then spiked by 99.31% to $77.0 million in 2023, then declined by 29.15% to $54.5 million in 2024.